26/09/2024  22:58:10 Chg. +0.300 Volume Bid22:58:10 Ask22:58:10 Market Capitalization Dividend Y. P/E Ratio
320.700EUR +0.09% -
Turnover: -
320.700Bid Size: - 325.900Ask Size: - 123.69 bill.EUR - -

Business description

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
 

Management board & Supervisory board

CEO
Kevin A. Lobo
Management board
Glenn Boehnlein, Yin Becker, Katy Fink, Rob Fletcher, Viju Menon, Andy Pierce, Spencer Stiles
Supervisory board
Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Srikant M. Datar, Giovanni Caforio, Lisa M. Skeete Tatum, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy
 

Company data

Name: Stryker Corporation
Address: 2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA
Phone: +1-269-385-2600
Fax: +1-269-385-1062
E-mail: -
Internet: www.stryker.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 31/12
Free Float: 64.10%
IPO date: 01/01/1979

Investor relations

Name: Jason Beach
IR phone: +1 269 385 2600
IR Fax: -
IR e-mail: r jason.beach@stryker.com

Company calendar

CW 40 | 30/09/2024 Ex-Dividend
CW 40 | 30/09/2024 Record Date
CW 44 | 31/10/2024 Dividend Payment
 

Main Shareholders

Others
 
62.26%
Vanguard Group Inc
 
8.17%
BlackRock Inc.
 
6.54%
Greenleaf Trust
 
4.85%
State Street Corporation
 
3.74%
Price T Rowe Associates Inc Md
 
3.29%
Wellington Management Group
 
3.19%
Capital Research Global Investor
 
2.67%
JP Morgan Chase & Co.
 
2.05%
Others
 
3.24%